Mariana Oncology
4 articles about Mariana Oncology
-
Mariana Oncology Announces $175 Million Series B Financing
9/7/2023
Mariana Oncology Inc., a biotechnology company pioneering a new era of radiopharmaceutical innovation to treat cancers with high unmet need, announced the closing of an oversubscribed $175 million Series B financing co-led by Deep Track Capital and Forbion.
-
Forbion co-leads $175 million Series B financing of Mariana Oncology as first investment of Forbion Ventures Fund VI
9/7/2023
Forbion, a leading European life sciences venture capital firm, announces that it has co-led, together with Deep Track Capital, an oversubscribed $175 million Series B financing in Mariana Oncology, the first investment by its Forbion Ventures Fund VI.
-
Mariana Oncology Expands Management Team, Appoints Linda Bain Chief Operating Officer and Chief Financial Officer
5/9/2023
Mariana Oncology today announced the appointment of Linda Bain as Chief Operating Officer and Chief Financial Officer.
-
BioSpace is proud to present its NextGen Bio “Class of 2023,” a list of the hottest recently launched life sciences companies in North America.